Patient leaflet - Aripiprazole Liconsa 10 mg tablets
s. how to store aripiprazole
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. contents of the pack and other infomation
What Aripiprazole tablets contains
- The active substance is aripiprazole. Aripiprazole 5 mg tablets: Each tablet contains 5 mg of aripiprazole.
Aripiprazole 10 mg tablets: Each tablet contains 10 mg of aripiprazole.
Aripiprazole 15 mg tablets: Each tablet contains 15 mg of aripiprazole.
Aripiprazole 30 mg tablets: Each tablet contains 30 mg of aripiprazole.
- The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, red iron oxide (E172).
Facts about Aripiprazole Liconsa 10 mg tablets
| Prescription needed? |
Yes, prescription-only medicine (POM) |
| Active substance |
Aripiprazole |
| Strength |
10 mg |
| Pharmaceutical form |
Oral tablet Aripiprazole Liconsa 10 mg tablets: Round biconvex pale pink tablet (diameter 7 mm). |
| How is it taken |
Oral |
| Excipients |
Lactose monohydrate, Maize starch, Microcrystalline cellulose, Hydroxypropyl cellulose, Magnesium stearate, Red Iron Oxide (E172) |
| Is it available? |
Listed as available
(NHS Dictionary of Medicines and Devices – not a record of current supplies)
|
| Shelf life |
3 years |
| Storage |
This medicinal product does not require any special storage conditions. |
| Drug group (ATC) |
Other antipsychotics
-
N Nervous system drugs
-
N05 Psycholeptics
-
N05A Antipsychotics
-
N05AX Other antipsychotics
-
N05AX12 aripiprazole
|
| Marketing authorisation |
PL 23218/0127 (first authorised 23 June 2020) |
| Marketing authorisation holder |
Laboratorios Liconsa, S.A. |
| Codes |
BNF 04020100 |
Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority.
Contains public sector information licensed under the Open Government Licence v3.0.